Role of the tumor necrosis factor ligand APRIL in Hodgkin's lymphoma: a retrospective study including 107 cases.
Went
Philip
P
Tzankov
Alexander
A
Schwaller
Juerg
J
Passweg
Jakob
J
Roosnek
Eddy
E
Huard
Bertrand
B
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D015331:Cohort Studies; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000175:diagnosis / Q000378:metabolism* / Q000628:therapy; D006801:Humans; D007150:Immunohistochemistry; D009367:Neoplasm Staging; D012008:Recurrence; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome; D053300:Tumor Necrosis Factor Ligand Superfamily Member 13 / Q000096:biosynthesis / Q000378:metabolism*
C114631:TNFSF13 protein, human; D053300:Tumor Necrosis Factor Ligand Superfamily Member 13